2B). DCs express TLRs which upon stimulation with TLR ligands induces the expression of maturation markers on the DC’s surface as shown for CD86 in Fig. 3. Whereas application of OVA and

OVA liposomes (maximum OVA concentration 5 μg/ml) did not stimulate the DCs, encapsulation of both TLR ligands had a clear effect on the DC activation. Application of 10 μg/ml PAM encapsulated in OVA-containing liposomes (OVA concentration 5 μg/ml) significantly elevated the MHCII and CD83 expression (p < 0.01) compared to untreated VX-809 purchase cells and this activation proved to be concentration dependent ( Fig. 4A and B). Moreover, a similar pattern was observed for the CD86 levels. After application of a PAM solution also a trend of elevated MHCII and CD83 levels was observed, but Tariquidar nmr these levels were not significantly higher compared to untreated DCs. PAM had a minor effect on the CD86 expression ( Fig. 4C). The effect of CpG encapsulation was more pronounced. Whereas a CpG solution did not activate the DCs at all, encapsulation of CpG in liposomes induced increased MHCII, CD83 and CD86 expression (Fig. 4D–F).

The level of expression obtained with the highest CpG concentration was comparable to that induced by LPS, the positive control. To investigate whether the improved DC activation ability in vitro correlated with the immunogenicity in mice, an immunisation study was performed. The liposomal formulations and physical

mixtures of OVA with CpG or PAM were applied ID. Both the OVA-specific total serum IgG titres ( Fig. 5A) and the antibody subclass (IgG1 and IgG2a, Fig. 5B) were measured. The addition of either during PAM or CpG into liposomes significantly increased the immunogenicity of OVA-loaded liposomes (p < 0.05), which did not enhance the immune response compared to an OVA solution. Incorporation of the TLR ligands in OVA-containing liposomes induced similar IgG titres as compared to the physical mixtures of OVA and the TLR ligand. However, the liposomes did influence the IgG1/IgG2a balance of the immune response ( Fig. 5B/C). The main IgG subtype induced by plain OVA was IgG1. The addition of PAM resulted in equally elevated IgG1 and IgG2a levels upon ID immunisation. Encapsulation of OVA alone in liposomes and co-encapsulation of OVA and PAM resulted in a tendency of altering the balance more towards IgG2a ( Fig. 5B/C). Co-administration of CpG with OVA significantly shifted the IgG1/IgG2a balance towards IgG2a (p < 0.05). This alteration was even more pronounced when OVA and CpG were co-encapsulated in liposomes (p < 0.001). Besides the humoral immune response, the effect of the different formulations on the cellular immunity was investigated by measuring the IFN-γ production by restimulated splenocytes. Th1 cells produce IFN-γ which is reported to induce isotype switching and IgG2a production [32] and [33].